Kaneka Corporation v. Glanbia Nutritionals, Inc.
1:20-cv-00232
Overview
Parties
Defendant
Anthem BioSciences Private Limited NPE (University / Research)
Represented By
0 Attorneys ListedGlanbia Nutritionals, Inc. Operating Company
Represented By
0 Attorneys ListedPlaintiff
Kaneka Corporation NPE (Individual / Inventor)
Represented By
0 Attorneys ListedCourt & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | Asserted Patent | View Official Patent → |
| π―π΅ Japan | Japan Counterpart | View Official Patent → | |
| π―π΅ Japan | Japan Counterpart | View Official Patent → | |
| π PCT International (WIPO) | PCT World Application | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7145044
Method of producing reduced coenzyme Q10 using solvent with high oxidation-protective effect
|
Filed: 2002-07-15
Issued: 2006-12-05
|
Expired (Term Ended)
+59d PTA
Expires: 2022-09-12
|
|
|
US7829080
Stabilization method of reduced coenzyme Q10
|
Filed: 2007-04-27
Issued: 2010-11-09
|
Expiring Soon (158 days)
Expires: 2027-04-27
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).